An amyloidosis diagnosis can take upwards of 2 years.Initial symptoms often are nondescript, and irreversible organ damage frequently occurs before disease confirmation.

MONTREAL — Levels of neurofilament light chain (Nfl) may be a biomarker of chemotherapy-induced peripheral neurotoxicity (PIPN), new research suggests. Investigators found Nfl levels increased in ...

In a recent study published in the journal Nature, researchers investigate whether pairs of unrelated B-cells of naive, unswitched, memory and plasmablast phenotypes that have similar heavy chains ...

Mortality trends (1999-2022) in patients with multiple myeloma with pneumonia, influenza, and COVID-19. Outcomes of myeloma cast nephropathy in the era of anti-CD38 monoclonal antibody-based frontline ...

On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of ...

Please provide your email address to receive an email when new articles are posted on . EMPHASIS study included 258 persons with MS given vidofludimus calcium or placebo for 24 weeks. Results show ...

In the companion to this commentary in JCO Oncology Practice, Dima et al 1 provided a scholarly review on the diagnosis, increased awareness, and treatment of immunoglobulin light chain (AL) ...

Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin light chains as insoluble amyloid fibrils in various tissues ...

Antibodies hold promise as therapeutic agents. However, their tendency to aggregate poses significant challenges to drug development. In a groundbreaking study, researchers now provide novel insights ...